SPC
Slate Path Capital’s Cue Biopharma CUE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-2,402,455
| Closed | -$1.82M | – | 53 |
|
|
2024
Q3 | $1.82M | Hold |
2,402,455
| – | – | 0.03% | 59 |
|
|
2024
Q2 | $2.98M | Hold |
2,402,455
| – | – | 0.06% | 51 |
|
|
2024
Q1 | $4.54M | Hold |
2,402,455
| – | – | 0.09% | 51 |
|
|
2023
Q4 | $6.34M | Hold |
2,402,455
| – | – | 0.14% | 50 |
|
|
2023
Q3 | $5.53M | Hold |
2,402,455
| – | – | 0.15% | 42 |
|
|
2023
Q2 | $8.77M | Hold |
2,402,455
| – | – | 0.32% | 36 |
|
|
2023
Q1 | $8.58M | Hold |
2,402,455
| – | – | 0.4% | 32 |
|
|
2022
Q4 | $6.85M | Buy |
2,402,455
+918,836
| +62% | +$2.62M | 0.37% | 32 |
|
|
2022
Q3 | $3.31M | Hold |
1,483,619
| – | – | 0.22% | 37 |
|
|
2022
Q2 | $3.69M | Hold |
1,483,619
| – | – | 0.23% | 36 |
|
|
2022
Q1 | $7.24M | Hold |
1,483,619
| – | – | 0.37% | 30 |
|
|
2021
Q4 | $16.8M | Hold |
1,483,619
| – | – | 0.88% | 24 |
|
|
2021
Q3 | $21.6M | Hold |
1,483,619
| – | – | 0.99% | 25 |
|
|
2021
Q2 | $17.3M | Hold |
1,483,619
| – | – | 0.97% | 22 |
|
|
2021
Q1 | $18.1M | Hold |
1,483,619
| – | – | 1.17% | 15 |
|
|
2020
Q4 | $18.6M | Hold |
1,483,619
| – | – | 1% | 16 |
|
|
2020
Q3 | $22.3M | Buy |
1,483,619
+612,925
| +70% | +$9.22M | 1.27% | 17 |
|
|
2020
Q2 | $21.3M | Hold |
870,694
| – | – | 1.26% | 15 |
|
|
2020
Q1 | $12.4M | Sell |
870,694
-19,306
| -2% | -$274K | 0.95% | 15 |
|
|
2019
Q4 | $14.1M | Hold |
890,000
| – | – | 0.76% | 16 |
|
|
2019
Q3 | $7.5M | Buy |
+890,000
| New | +$7.5M | 0.5% | 16 |
|